Scientific Sessions 2024  /  Global Opportunities to Advance Health and Hope: AHA’s 2nd Century Priorities and Global Opportunities in Research  /  International Collaboration in Multinational Clinical Trials
Logo

American Heart Association

  3
  0

Final ID:

International Collaboration in Multinational Clinical Trials

  • Faubert, Christine  ( Heart and Stroke , Toronto , Ontario , Canada )
  • Tancredi, David  ( LEDUCQ FOUNDATION , Boston , Massachusetts , United States )
  • Prabhakaran, Dorairaj  ( Centre for Chronic Disease Control , Delhi , India )
    • Author Disclosures:
    Christine Faubert: No Answer | David Tancredi: DO NOT have relevant financial relationships | Dorairaj Prabhakaran: DO have relevant financial relationships ; Research Funding (PI or named investigator):SERDIA PHARMACEUTICALS (INDIA) PRIVATE LIMITED:Past (completed) ; Research Funding (PI or named investigator):Servier Affaires Médicales:Active (exists now) ; Research Funding (PI or named investigator):Imperial College London:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Global Opportunities to Advance Health and Hope: AHA’s 2nd Century Priorities and Global Opportunities in Research

Friday, 11/15/2024 , 12:30PM - 01:45PM

Cardiovascular Seminar

More abstracts on this topic:
AHA’s 2nd Century Priorities: History of AHA International and What’s Next

Smith Sidney, Kazi Dhruv

Moderated Panel Discussion: Addressing Research Challenges Through Collaboration

Prabhakaran Dorairaj, Zhao Dong, Ogola Elijah, Ma Changsheng, Baranchuk Adrian

More abstracts from these authors:
Discussant: BPROAD

Prabhakaran Dorairaj

Fixed-dose combination therapy: Opportunities and challenges for improved CVD prevention

Prabhakaran Dorairaj, Murphy Adrianna, Irazola Vilma

You have to be authorized to contact abstract author. Please, Login
Not Available